KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Interest Expenses (2016 - 2025)

Amgen has reported Interest Expenses over the past 17 years, most recently at $653.0 million for Q4 2025.

  • Quarterly results put Interest Expenses at $653.0 million for Q4 2025, down 12.58% from a year ago — trailing twelve months through Dec 2025 was $2.8 billion (down 12.68% YoY), and the annual figure for FY2025 was $2.8 billion, down 12.68%.
  • Interest Expenses for Q4 2025 was $653.0 million at Amgen, down from $685.0 million in the prior quarter.
  • Over the last five years, Interest Expenses for AMGN hit a ceiling of $824.0 million in Q1 2024 and a floor of $281.0 million in Q2 2021.
  • Median Interest Expenses over the past 5 years was $669.0 million (2025), compared with a mean of $569.4 million.
  • Biggest five-year swings in Interest Expenses: dropped 17.63% in 2021 and later soared 129.27% in 2023.
  • Amgen's Interest Expenses stood at $335.0 million in 2021, then rose by 23.88% to $415.0 million in 2022, then surged by 97.83% to $821.0 million in 2023, then dropped by 9.01% to $747.0 million in 2024, then dropped by 12.58% to $653.0 million in 2025.
  • The last three reported values for Interest Expenses were $653.0 million (Q4 2025), $685.0 million (Q3 2025), and $694.0 million (Q2 2025) per Business Quant data.